Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors
Marco Merlo1, Enrico Ammirati2, Piero Gentile1
1Cardiovascular Department, Azienda Sanitaria Universitaria Integrata (ASUITS) and University of Trieste, Trieste, Italy.
Insights
Persistent left ventricular dysfunction is common in acute lymphocytic myocarditis survivors. Initial heart damage and inflammation predict long-term systolic impairment, impacting over half of patients.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Persistent left ventricular (LV) systolic dysfunction following acute lymphocytic myocarditis (LM) is not well understood.
- Assessing the frequency and predictors of persistent LV dysfunction in LM patients with reduced ejection fraction is crucial.
Purpose of the Study:
- To determine the occurrence of persistent LV dysfunction in acute LM patients.
- To identify factors predicting long-term LV systolic impairment after LM.
Main Methods:
- Retrospective analysis of 48 patients with LM, reduced ejection fraction, and 1-year echocardiography.
- Multivariate analysis to identify predictors of LV dysfunction at 1-year follow-up.
Main Results:
- Over half (56.3%) of patients exhibited persistent LV dysfunction (LVEF <50%) at 1 year.
- Predictors included larger LV end-diastolic diameter, non-fulminant presentation, and poor lymphocytic infiltrate.
- Lower pre-discharge LVEF was the strongest predictor (AUC 0.95).
Conclusions:
- Persistent LV dysfunction is frequent in acute LM survivors.
- Early signs of myocardial damage and inflammation predict long-term outcomes.
Background:
Persistent left ventricular (LV) systolic dysfunction in patients with acute lymphocytic myocarditis (LM) is widely unexplored.
Objectives:
To assess the frequency and predictors of persistent LV dysfunction in patients with LM and reduced LVEF at admission.
Methods And Results:
We retrospectively evaluated 89 consecutive patients with histologically-proven acute myocarditis enrolled at three Italian referral hospitals. A subgroup of 48 patients with LM, baseline systolic impairment and an available echocardiographic assessment at 12 months (6-18) from discharge constituted the study population. The primary study end-point was persistent LV dysfunction, defined as LVEF <50% at 1-year, and was observed in 27/48 patients (56.3%). Higher LV end-diastolic diameter at admission (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.04-1.43, p = 0.002), non-fulminant presentation (OR 8.46, 95% CI 1.28-55.75, p = 0.013) and presence of a poor lymphocytic infiltrate (OR 12.40, 95% CI 1.23-124.97, p = 0.010) emerged as independent predictors of persistent LV dysfunction at multivariate analysis (area under the curve 0.91, 95% CI 0.82-0.99). Pre-discharge LVEF was lower in patients with persistent LV dysfunction compared to the others (32%±8 vs. 53%±8, p <0.001), and this single variable showed the best accuracy in predicting the study end-point (area under the curve 0.95, 95% CI 0.89-1.00).
Conclusions:
More than half of patients presenting with acute LM and LVEF <50% who survive the acute phase show persistent LV dysfunction after 1-year from hospital discharge. Features of subacute inflammatory process and of established myocardial damage at initial hospitalization emerged as predictors of this end-point.
More Related Videos
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Frequency-dependent Selection
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
What is a Frequency Distribution


